References
- Bijur GN, Jope RS (2003). Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem, 87, 1427-35. https://doi.org/10.1046/j.1471-4159.2003.02113.x
- Blum R, Jacob-Hirsch J, Amariglio N, et al (2005). Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death. Cancer Res, 65, 999-1006.
- Boardman LA (2009). Overexpression of MACC1 leads to downstream activation of HGF/MET and potentiates metastasis and recurrence of colorectal cancer.. Genome medicine, 1, 36. https://doi.org/10.1186/gm36
- Bobarykina AY, Minchenko DO, Opentanova IL, et al (2006). Hypoxic regulation of PFKFB-3 and PFKFB-4 gene expression in gastric and pancreatic cancer cell lines and expression of PFKFB genes in gastric cancers. Acta Biochim Pol, 53, 789-99.
- Bosca L, Mojena M, Ghysdael J (1986). Expression of the v-src or v-fps oncogene increases fructose 2, 6-bisphosphate in chick-embryo fibroblasts. Novel mechanism for the stimulation of glycolysis by retroviruses. Biochem J, 236, 595-9.
- Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
- Gao, J, Ding F, Liu Q (2013). Knockdown of MACC1 expression suppressed hepatocellular carcinoma cell migration and invasion and inhibited expression of MMP2 and MMP9. Mol Cell Biochem, 376, 21-32. https://doi.org/10.1007/s11010-012-1545-y
- Gottlob K FAU Majewski N, Majewski N FAU Kennedy S, Kennedy S FAU Kandel E, et al (2001). - Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. Genes Dev, 15, 1406-18. https://doi.org/10.1101/gad.889901
- Kawauchi K, Araki K, Tobiume K, & Tanaka N (2008). p53 regulates glucose metabolism through an IKK-NF-kappaB pathway and inhibits cell transformation. Nat Cell Biol, 10, 611-8. https://doi.org/10.1038/ncb1724
- Kokoszynska K, Krynski J, Rychlewski L, et al (2009). Unexpected domain composition of MACC1 links MET signaling and apoptosis. Acta Biochimica Polonica, 56, 317-323.
- Minchenko OH, Opentanova IL, Ogura T, et al (2005). Expression and hypoxia-respo -nsiveness of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 inmammary gland malignant cell lines. Acta Biochim Pol, 52, 881-8.
- Moon JS, Jin W J, Kwak, JH, et al (2011). Androgen stimulates glyco-lysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 in prostate cancer cells. Biochem J, 433, 225-33. https://doi.org/10.1042/BJ20101104
- Novellasdemunt L, Tato I, Navarro-Sabate A, et al (2013). Aktdependent activation of heart 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase (PFKFB2) isoenzyme by amino acids. J Biol Chem, 288, 10640-51. https://doi.org/10.1074/jbc.M113.455998
- Neary CL FAU Pastorino JG, & Pastorino JG (2013). - Akt inhibition promotes hexokinase 2 redistribution and glucose uptake in cancer cells. J Cell Physiol, 228, 1943-8. https://doi.org/10.1002/jcp.24361
- Okar DA, Manzano A, Navarro-Sabate A, et al (2001). PFK-2/FBPase-2: maker and breaker of the essential biofactor fructose-2, 6-bisphosphate. Trends Biochem Sci, 26, 30-35. https://doi.org/10.1016/S0968-0004(00)01699-6
- Pelicano H , Martin DS, Xu RH, & Huang P (2006). Glycolysis inhibition for anticancer treatment. Oncogene, 25, 4633-46. https://doi.org/10.1038/sj.onc.1209597
- Rider MH, Bertrand L, Vertommen D, et al (2004). 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase: head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J, 381, 561-79. https://doi.org/10.1042/BJ20040752
- Roberts DJ, Tan-Sah VP, Tan-Sah VP, et al (2013). Akt phosphorylates HK-II at Thr-473 and increases mitochondrial HK-II association to protect cardiomyocytes. J Biol Chem, 288, 32638. https://doi.org/10.1074/jbc.A113.482026
- Scatena R, Bottoni P, Pontoglio A, Mastrototaro L, Giardina B (2008). Glycolytic enzyme inhibitors in cancer treatment. Expert Opin Investig Drugs, 17, 1533-45. https://doi.org/10.1517/13543784.17.10.1533
- Stein U, Smith J, Walther W, Arlt F (2009). MACC1 controls Met: what a difference an Sp1 site makes. Cell Cycle, 8, 2467-9. https://doi.org/10.4161/cc.8.15.9018
- Stein U, Walther W, Arlt F, et al (2009). MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med, 15, 59-67. https://doi.org/10.1038/nm.1889
- Van Schaftingen E (1987). Fructose 2, 6-bisphosphate. Adv Enzymol Relat Areas Mol Biol, 59, 315-95.
- WARBURG O (1956). On the origin of cancer cells. Science, 123, 309-314. https://doi.org/10.1126/science.123.3191.309
- Yalcin A, Clem BF, Simmons A, et al (2009). Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem, 284, 24223-32. https://doi.org/10.1074/jbc.M109.016816
- Zeller KI, Zhao X, Lee CW, et al (2006). Global mapping of c-Myc binding sites and target gene networks in human B cells. Proc Natl Acad Sci USA, 103, 17834-9. https://doi.org/10.1073/pnas.0604129103
Cited by
- Clinical Significance of Joint Detection of Serum VEGF, SIL-2R and HGF in Patients with Primary Hepatocellular Carcinoma before and after Percutaneous Microwave Coagulation Therapy vol.15, pp.11, 2014, https://doi.org/10.7314/APJCP.2014.15.11.4545
- Serum Peroxiredoxin3 is a Useful Biomarker for Early Diagnosis and Assessemnt of Prognosis of Hepatocellular Carcinoma in Chinese Patients vol.15, pp.7, 2014, https://doi.org/10.7314/APJCP.2014.15.7.2979
- DEP Domain Containing 1 is a Novel Diagnostic Marker and Prognostic Predictor for Hepatocellular Carcinoma vol.15, pp.24, 2015, https://doi.org/10.7314/APJCP.2014.15.24.10917
- MACC1 overexpression and survival in solid tumors: a meta-analysis vol.36, pp.2, 2015, https://doi.org/10.1007/s13277-014-2736-9
- In silico discovery of significant pathways in colorectal cancer metastasis using a two-stage optimisation approach vol.9, pp.6, 2015, https://doi.org/10.1049/iet-syb.2015.0031
- Single Nucleotide Polymorphisms as Prognostic and Predictive Factors of Adjuvant Chemotherapy in Colorectal Cancer of Stages I and II vol.2016, pp.1687-630X, 2016, https://doi.org/10.1155/2016/2139489
- Prognostic Classifier Based on Genome-Wide DNA Methylation Profiling in Well-Differentiated Thyroid Tumors vol.102, pp.11, 2017, https://doi.org/10.1210/jc.2017-00881
- Metastasis-associated in colon cancer 1: A promising biomarker for the metastasis and prognosis of colorectal cancer vol.14, pp.4, 2017, https://doi.org/10.3892/ol.2017.6670
- SLIT2/ROBO1 axis contributes to the Warburg effect in osteosarcoma through activation of SRC/ERK/c-MYC/PFKFB2 pathway vol.9, pp.3, 2018, https://doi.org/10.1038/s41419-018-0419-y
- Fructose 2,6-Bisphosphate in Cancer Cell Metabolism vol.8, pp.2234-943X, 2018, https://doi.org/10.3389/fonc.2018.00331
- Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study vol.15, pp.1, 2015, https://doi.org/10.1186/s12885-015-1150-z
- MACC1—the first decade of a key metastasis molecule from gene discovery to clinical translation vol.37, pp.4, 2018, https://doi.org/10.1007/s10555-018-9771-8
- Prognostic and Risk Stratification Value of Lesion MACC1 Expression in Colorectal Cancer Patients vol.9, pp.2234-943X, 2019, https://doi.org/10.3389/fonc.2019.00028